Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1988 May;41(5):540–546. doi: 10.1136/jcp.41.5.540

Flat in situ carcinoma of the bladder: cytological examination of urine in diagnosis, follow up, and assessment of response to chemotherapy.

W J Highman 1
PMCID: PMC1141508  PMID: 3384985

Abstract

Urine cytology was performed for the diagnosis and follow up of flat carcinoma in situ (CIS) of the bladder in a series of 35 patients without associated or previous bladder tumours. Ninety six per cent had positive or suspicious cytology at initial presentation. There were no false positive reports. Cytological diagnosis of malignancy was made before biopsy in 24 patients: CIS in voided urine presents as flat sheets of five to 15 cells with features of high grade malignancy. Development of tumour during follow up was suggested by the appearance of large thick sheets and clusters of 30 or more malignant cells which were large and pleomorphic in high grade tumours and relatively small and closely cohesive in low grade tumours. Eleven of 13 patients with these clusters had bladder or ureteric tumours and two had malignant disease in the prostate. Negative cytological results in the presence of degenerative changes caused by chemotherapy was an unreliable indicator of response to chemotherapy, and there were five patients with false negative reports during treatment, of whom three had developed tumour. Persistence of malignant cells with features similar to those seen in the urine before treatment reliably predicted failure to respond to chemotherapy.

Full text

PDF
543

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed M. N., Lushpihan A., Louis C., Seemayer T. A., Thelmo W. L., Wang N. S. Cytology of transitional cell carcinoma in situ of urinary bladder with extensive prostatic involvement. Urology. 1976 May;7(5):538–540. doi: 10.1016/0090-4295(76)90203-x. [DOI] [PubMed] [Google Scholar]
  2. Boon M. E., Blomjous C. E., Zwartendijk J., Heinhuis R. J., Ooms E. C. Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes. Acta Cytol. 1986 Jul-Aug;30(4):360–366. [PubMed] [Google Scholar]
  3. Cant J. D., Murphy W. M., Soloway M. S. Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer. Cancer. 1986 Jun 1;57(11):2119–2122. doi: 10.1002/1097-0142(19860601)57:11<2119::aid-cncr2820571105>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  4. FORNI A. M., KOSS L. G., GELLER W. CYTOLOGICAL STUDY OF THE EFFECT OF CYCLOPHOSPHAMIDE ON THE EPITHELIUM OF THE URINARY BLADDER IN MAN. Cancer. 1964 Oct;17:1348–1355. doi: 10.1002/1097-0142(196410)17:10<1348::aid-cncr2820171017>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  5. Farrow G. M., Utz D. C., Rife C. C., Greene L. F. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res. 1977 Aug;37(8 Pt 2):2794–2798. [PubMed] [Google Scholar]
  6. Fukui I., Yokokawa M., Sekine H., Yamada T., Hosoda K., Ishiwata D., Oka K., Sarada T., Tohma T., Yamada T. Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment. Cancer. 1987 Jan 1;59(1):164–173. doi: 10.1002/1097-0142(19870101)59:1<164::aid-cncr2820590132>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  7. Geisse L. J., Tweeddale D. N. Pre-clinical cytological diagnosis of bladder cancer. J Urol. 1978 Jul;120(1):51–56. doi: 10.1016/s0022-5347(17)57036-6. [DOI] [PubMed] [Google Scholar]
  8. Heney N. M., Szyfelbein W. M., Daly J. J., Prout G. R., Bredin H. C. Positive urinary cytology in patients without evident tumor. J Urol. 1977 Feb;117(2):223–224. doi: 10.1016/s0022-5347(17)58408-6. [DOI] [PubMed] [Google Scholar]
  9. Murphy W. M., Soloway M. S., Jukkola A. F., Crabtree W. N., Ford K. S. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer. 1984 Apr 1;53(7):1555–1565. doi: 10.1002/1097-0142(19840401)53:7<1555::aid-cncr2820530723>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  10. Nelson R. P. New concepts in staging and follow-up of bladder carcinoma. Urology. 1983 Feb;21(2):105–112. doi: 10.1016/0090-4295(83)90001-8. [DOI] [PubMed] [Google Scholar]
  11. Prout G. R., Jr, Griffin P. P., Daly J. J., Heney N. M. Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer. 1983 Aug 1;52(3):524–532. doi: 10.1002/1097-0142(19830801)52:3<524::aid-cncr2820520324>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  12. Rasmussen K., Peterson B. L., Jacobo E., Penick G. D., Sall J. Cytologic effects of Thiotepa and Adriamycin on normal canine urothelium. Acta Cytol. 1980 May-Jun;24(3):237–243. [PubMed] [Google Scholar]
  13. VOUTSA N. G., MELAMED M. R. CYTOLOGY OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER. Cancer. 1963 Oct;16:1307–1316. doi: 10.1002/1097-0142(196310)16:10<1307::aid-cncr2820161012>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  14. Weinstein R. S., Coon J. S., Schwartz D., Miller A. W., 3rd, Pauli B. U. Pathology of superficial bladder cancer with emphasis on carcinoma in situ. Urology. 1985 Oct;26(4 Suppl):2–10. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES